Author

Jawan W. Abdulrahim

Duke UniversityORCID 0000-0002-7232-2311Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:GWAS summary statistics· 2 Organism:human· 2 Approach:statistical model· 2 Research Focus:differential expression· 1 Assay:electronic health records· 1 Research Focus:GWAS / association mapping· 1 Research Focus:variant calling· 1

Frequent Co-Authors

Jessica A. ReganiD· 2 shared Lydia Coulter KweeiD· 2 shared Svati Hasmukh ShahiD· 2 shared Carol HaynesiD· 1 shared Kaitlyn AmosiD· 1 shared Kalyani KottililiD· 1 shared Kristin CoreyiD· 1 shared Manesh PateliD· 1 shared

Activity by Year

2022-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 35 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersGenetic & Genomic Medicine

Jessica A. ReganORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Comprehensive Comparison of a Genotype-Forward vs. Phenotype-Forward Approach for Monogenic Cardiovascular Diseases in the UK Biobank Cohort

Megan E. Ramaker, Kristin Corey, Jessica A. Regan, Sara A. Coles, Jawan W. Abdulrahim, Kalyani Kottilil, Navid A. Nafissi, Kaitlyn Amos, Meghan Mac Neal, Lydia Coulter Kwee, Senthil Selvaraj, Svati Hasmukh Shah

This study compares genotype-forward and phenotype-forward approaches for detecting monogenic cardiovascular diseases in the UK Biobank, finding the genotype-forward method has a higher diagnostic yield.

medRxiv · Sep 11, 2025 · PreprintGenetic & Genomic Medicine

A Phenome Wide Association Study of Severe COVID-19 Genetic Risk Variants

Jessica A. Regan, Jawan W. Abdulrahim, Nathan A. Bihlmeyer, Carol Haynes, Lydia Coulter Kwee, Manesh Patel, Svati H. Shah

This study identifies novel comorbidities associated with genetic risk variants for severe COVID-19 using a PheWAS approach in large cohorts.

Journal of the American Heart Association · Feb 18, 2022Peer-reviewedGenetic & Genomic Medicine